Upgrade to SI Premium - Free Trial

NRx Pharmaceuticals (NRXP) Reports In-Line Q1 EPS

May 18, 2026 7:52 AM

NRx Pharmaceuticals (NASDAQ: NRXP) reported Q1 EPS of $0.00. Revenue for the quarter came in at $1.07 million.

For earnings history and earnings-related data on NRx Pharmaceuticals (NRXP) click here.

Categories

Earnings